Reduced Generation of Multiple Motile Cilia: A severe novel respiratory ciliopathy
Reduced Generation of Multiple Motile Cilia: A severe novel respiratory ciliopathy
批准号:
325271870
负责人:
Professor Dr. Heymut Omran
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2022-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Multiple motile cilia line our airways and make an essential contribution to clearing the upper and lower respiratory tract to prevent infection and chronic inflammatory. We have been able to describe a novel motile ciliopathy within the group of mucociliary clearance disorders: Reduced Generation of Multiple Motile Cilia (RGMC). RGMC affected suffer from chronic destructive airway disease. Unfortunatelly RGMC is difficult to diagnose because secondary changes caused by inflammation can resemble the picture seen in respiratory epithelia of RGMC affected. In RGMC there is markedly reduced formation of cilia and/or ciliated cells due to autosomal recessive mutations in CCNO and MCIDAS. In the first funding period among other novel gene defects (e.g. NEK10) we identified recessive TP73 and autosomal dominant de novo mutations in FOXJ1 causing RGMC with lissencephaly and hydrocephalus, respectively. Our previous studies indicated that in CCNO and MCIDAS mutant respiratory epithelia the number of basal bodies and cilia is severely reduced. While the number of basal bodies was not severely altered in TP73 and FOXJ1 mutant cells the number of cilia was reduced. Our analyses in airliquid interface cultures of TP73 mutant respiratory epithelia revealed that not only the process of ciliogenesis is affected, but also cell proliferation and or differentiation of the respiratory epithelia is altered. This is of high clinical importance because changes in cell composition enable a new deeper understanding of the underlying disease mechanisms. Within this project we will therefore further i. characterize the process of human multiciliogenesis, cell differentiation and cell proliferation in new and already known RGMC defects ii. perform identification and characterization of further RGMC individuals as well as novel genes related to RGMC using next generation sequencing approaches iii. perform genotype-phenotype analysis in RGMC affected.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular characterization of radial spoke composition and defects in Primary Ciliary Dyskinesia
-
批准号:425347732
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Heymut Omran
-
依托单位:
NPHP-related polycystic kidney disease in man and mice
-
批准号:77903122
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Heymut Omran
-
依托单位:
Molecular characterization of outer dynein arm defects in Primary Ciliary Dyskinesia (PCD)
-
批准号:27604571
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Professor Dr. Heymut Omran
-
依托单位:
Genetische und molekulare Charakterisierung der Primären Ciliären Dyskinesie (PCD) verursacht durch DNAH5-Mutationen
-
批准号:5272006
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:Professor Dr. Heymut Omran
-
依托单位:
Identifikation, molekulare Charakterisierung und Funktionsanalyse des Gens NPHP3 für adoleszente Nephronophthise sowie SLS1 für das Senior-Loken Syndrom
-
批准号:5108790
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:Professor Dr. Heymut Omran
-
依托单位:
The role of cytoplasmic pre-assembly of axonemal components in primary ciliary dyskinesia
-
批准号:274886879
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Heymut Omran
-
依托单位:
Male infertility caused by defective sperm flagella beat generation due to ODA defects
-
批准号:388866151
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Heymut Omran
-
依托单位:
Molecular characterization of defects of the central pair complex of cilia causing Primary Ciliary Dyskinesia (PCD)
-
批准号:269498644
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Heymut Omran
-
依托单位:
国内基金
海外基金
Next Generation Majorana Nanowire Hybrids
-
批准号:--
-
项目类别:--
-
资助金额:20万元
-
批准年份:2020
-
负责人:Panagiotis Kotetes
-
依托单位: